When different materials transition from one phase to another, such as water coming to a boil or a magnet losing its ability ...
The financing will advance EPI-321, Epicrispr's lead clinical candidate currently in first-in-human studies for facioscapulohumeral muscular dystrophy (FSHD), accelerate its pipeline of programmable ...
The European Medicines Agency (EMA) is holding a consultation about a draft framework intended to cut the time it takes to ...
In analogue RFoF the RF waveform is directly modulated onto an optical carrier, providing transparent signal transport with ...
For decades, engineers have known that the terahertz frequency range — the electromagnetic band between roughly 0.1 and 10 terahertz (THz), sitting awkwardly between the reach of electronics and ...
EEG neurofeedback as a method to modulate brain activity prior to painful stimulation and examined its effect on pain perception in a well-powered, double-blind study. Results showed that real, but ...
Reporting in the journal Nature, a collaboration between the experimental group of Caltech’s Manuel Endres, professor of ...
Collaboration-driven semiconductor technologies are transforming electric vehicles into a practical, everyday option.
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic ...
PI's Fast, Multi-Channel Photonics Alignment (FMPA) technology is a collection of firmware-level commands built into the company's highest-performing digital nanopositioning and hexapod controllers.
Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track Soquelitinib’s potential in atopic dermatitis and ...
MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results